Literature DB >> 9474395

The prognostic value of quantitative bone scan in knee osteochondritis dissecans. A preliminary experience.

G A Paletta1, P A Bednarz, C L Stanitski, G A Sandman, D F Stanitski, S Kottamasu.   

Abstract

We reviewed the records of 12 patients ages 9 to 16 years with knee osteochondritis dissecans. All patients had clinical histories and examinations, four radiographic views of the knee, and technetium-99m diphosphonate quantitative bone scans. Scan results (symmetric, increased, or decreased activity), clinical course, healing time, and final outcome were correlated to determine the prognostic value of the scan. We divided the patients into those with open physes (distal femoral and proximal tibial) and those with closed physes. Four of the six patients with open physes had increased activity on the bone scan. All four of these knees healed with nonsurgical treatment. The other two patients had decreased activity on bone scan, and both required surgical treatment after nonsurgical treatment failed. Of the six patients with closed physes, all had increased activity on the bone scan, but only two patients had healing of the osteochondral lesion without surgery. Quantitative bone scanning had a 100% predictive value for the prognosis in osteochondritis dissecans patients with open physes, but for those with closed physes the predictive value was less. Because the natural history in the adolescent group is less predictable, it is in this group that the quantitative scan would be most helpful. In this small group of patients, quantitative bone scanning had limited prognostic value.

Entities:  

Mesh:

Year:  1998        PMID: 9474395     DOI: 10.1177/03635465980260012901

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  10 in total

Review 1.  Osteochondritis Dissecans: Etiology, Pathology, and Imaging with a Special Focus on the Knee Joint.

Authors:  Juergen Bruns; Mathias Werner; Christian Habermann
Journal:  Cartilage       Date:  2017-06-22       Impact factor: 4.634

2.  Osteochondritis dissecans of the knee.

Authors:  Giacomo Zanon; Giovanni DI Vico; Matteo Marullo
Journal:  Joints       Date:  2014-05-08

Review 3.  A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from König to the ROCK study group.

Authors:  Eric W Edmonds; John Polousky
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

4.  Osteochondritis Dissecans of the Knee - Conservative Treatment Strategies: A Systematic Review.

Authors:  Luca Andriolo; Christian Candrian; Tiziana Papio; Alessia Cavicchioli; Francesco Perdisa; Giuseppe Filardo
Journal:  Cartilage       Date:  2018-02-22       Impact factor: 4.634

5.  Knee osteochondritis dissecans-treatment technical aspects.

Authors:  Mats Brittberg
Journal:  J Orthop       Date:  2022-08-11

6.  Long term results of operative treatment of knee osteochondritis dissecans.

Authors:  Samo K Fokter; Andrej Strahovnik; Darjan Kos; Andraž Dovnik; Nina Fokter
Journal:  Wien Klin Wochenschr       Date:  2012-09-05       Impact factor: 1.704

Review 7.  Osteochondritis Dissecans: Current Understanding of Epidemiology, Etiology, Management, and Outcomes.

Authors:  Michael M Chau; Mikhail A Klimstra; Kelsey L Wise; Jutta M Ellermann; Ferenc Tóth; Cathy S Carlson; Bradley J Nelson; Marc A Tompkins
Journal:  J Bone Joint Surg Am       Date:  2021-06-16       Impact factor: 6.558

8.  Osteochondral Allograft for Unsalvageable Osteochondritis Dissecans in the Skeletally Immature Knee.

Authors:  Breann Tisano; Henry B Ellis; Chuck Wyatt; Philip L Wilson
Journal:  Orthop J Sports Med       Date:  2022-02-11

9.  OSTEOCHONDRITIS DISSECANS OF THE KNEE: DIAGNOSIS AND TREATMENT.

Authors:  Luiz Aurélio Mestriner
Journal:  Rev Bras Ortop       Date:  2015-11-04

Review 10.  Grade I Osteochondritis Dissecans in a Young Professional Athlete.

Authors:  Vinod Kumar; Nishit Bhatnagar; Jeetendra Singh Lodhi
Journal:  Indian J Orthop       Date:  2018 Jul-Aug       Impact factor: 1.251

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.